Significance, detection and markers of disseminated breast cancer cells
about
Dynamic changes in numbers and properties of circulating tumor cells and their potential applicationsA perspective on cancer cell metastasisAnalysis of kinase gene expression patterns across 5681 human tissue samples reveals functional genomic taxonomy of the kinomemRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancerMutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis.Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration.Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma.The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Bimodal gene expression patterns in breast cancerClinical relevance and current challenges of research on disseminating tumor cells in cancer patientsAssessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.Enhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs)Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers.Neighborhood rough set reduction-based gene selection and prioritization for gene expression profile analysis and molecular cancer classification.GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2).miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.Molecular basis of metastasis.New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrenceTrefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinomaComparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsVav1 fine tunes p53 control of apoptosis versus proliferation in breast cancerA prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.Lobular carcinoma of the breast with gastrointestinal metastasis.Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 inductionSelection of brain metastasis-initiating breast cancer cells determined by growth on hard agar.The role of radiotherapy-resistant stem cells in breast cancer recurrence.Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma.Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer.Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.Bone Marrow Micrometastases in Breast Cancer Patients: A Long-Term Follow-up Study.Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Safety of ovarian tissue autotransplantation for cancer patients.Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.In vivo capture and label-free detection of early metastatic cells.Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancerExpression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancersPreoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma.Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms.
P2860
Q26853569-4AC3AB17-500C-461F-A7E8-14AFFB70F6A8Q28307891-991B10E5-3040-4ECC-A5E0-9007F0A1ABECQ28476427-965D5178-7321-4FB9-954D-0DE8A5F0290CQ28543647-38F66E45-7950-4303-A670-26300B6E9989Q30572690-36889CBB-DFB0-4475-90E9-427BD1F88DFFQ30940749-2A167B28-5BA9-4C63-90C7-DBF3C33158DDQ30955321-9964D30E-04E0-45F7-AC09-9EAF4E18B7AEQ30978083-16937027-2DDD-4D73-BAEF-79B36F428810Q33531526-D8B366B0-F0AF-4CA1-8BED-594FB8E89756Q33555492-2645B866-F03F-41B6-9B9D-692A8BD9F0B1Q33762644-B6661A91-EC15-4FFC-B1F8-50D171C437DDQ33879279-E991B1F9-16E2-413C-8350-00B21D4D8191Q33905866-EBF49689-438D-4423-A249-8024A720B5EFQ33960955-71FFE25E-F105-46DD-B7B9-F2352B6E11BFQ34107170-CDDCBA9D-9C98-48A8-94CB-6E511E3CC844Q34120552-90569E19-C152-4E0B-8558-326E7FF707D5Q34200701-62B8D279-0572-401A-BE61-5123360D12DCQ34304177-EAD49049-F9F2-4421-81E2-6D50C1526549Q34382914-8013DB24-C13B-4722-BD11-4CF9F424C211Q34411725-B9DC752C-078B-4C3D-BE4B-2E2E22ADC870Q34468675-234474C0-2BAF-4865-9208-26CDC7848283Q34559351-F4524B64-E0AF-4A70-A6CB-7214816C1DFDQ34658145-F91B06FE-A855-40D8-A8A9-7F0C26AC14CBQ34689083-65A586B1-F37A-444A-AED0-830B8AB1EA8EQ34722767-58BFDFA3-7621-4FAD-8622-44324D14429CQ34838868-1012E62C-10FB-453C-9E39-AFDE5B4F8B9BQ34972167-2632F5A0-8656-4CB2-A6B3-99DFF765261FQ34977042-9D10B71C-7A97-45C3-9EF8-89F4D5FB295CQ35000231-87BF7997-F9B2-44AE-9276-E48DAF7D93B2Q35113022-3297C794-9D92-4D16-89EA-00C78690FADCQ35120439-3580B8F2-47EB-441D-B580-BDE16D4E89DAQ35181065-908216C1-9228-43FD-88B2-92BAAD85D233Q35459525-B551058E-83F1-42AF-AC89-04057FF8AA5CQ35664382-EAA1942D-C5A3-4A8F-AE6E-474651D2F1E6Q35847118-0628B445-9D42-4846-8051-3D0B41D52AFDQ36040727-9F15BA78-15A2-41EF-92F7-D21AE1952302Q36213198-67B29904-AB88-476E-B1FF-7F262D6C5B37Q36477512-11E1C074-25F7-45E6-8070-D8452E116914Q36544559-53FAA7BE-4128-40D7-88AD-10122CE6DD4AQ36570772-7421153C-0B2E-4114-9F30-24BD2D867E7B
P2860
Significance, detection and markers of disseminated breast cancer cells
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Significance, detection and markers of disseminated breast cancer cells
@ast
Significance, detection and markers of disseminated breast cancer cells
@en
Significance, detection and markers of disseminated breast cancer cells
@nl
type
label
Significance, detection and markers of disseminated breast cancer cells
@ast
Significance, detection and markers of disseminated breast cancer cells
@en
Significance, detection and markers of disseminated breast cancer cells
@nl
prefLabel
Significance, detection and markers of disseminated breast cancer cells
@ast
Significance, detection and markers of disseminated breast cancer cells
@en
Significance, detection and markers of disseminated breast cancer cells
@nl
P3181
P356
P1476
Significance, detection and markers of disseminated breast cancer cells
@en
P2093
Marc Lacroix
P304
P3181
P356
10.1677/ERC-06-0001
P407
P577
2006-12-01T00:00:00Z